Abstract
Estimation of FGF-3 oncogene amplification in DNA samples extracted from paraffin embedded sections of 136 ovarian cancer samples was carried out by a quantitative PCR method. The aim of this study was to elucidate a possible association of FGF-3 copy numbers with established prognostic factors such as age, histology, FIGO stage, grading, postoperative residual tumour mass, ascites, hormone receptor content and preoperative CA 125 serum levels. In addition, correlation of FGF-3 amplification with overall survival of the patients was assessed. There was a borderline positive correlation between preoperative CA 125 serum levels and the degree of amplification of the FGF-3 gene (P = 0.06). A statistically significant association of FIGO-stage with FGF-3 copy number could be found (P = 0.008). No correlation between FGF-3 amplification and overall survival was noted. The data combine to suggest that FGF-3 is an indicator of aggressiveness of ovarian cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosen, A., Sevelda, P., Klein, M. et al. First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. Br J Cancer 67, 1122–1125 (1993). https://doi.org/10.1038/bjc.1993.206
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.206
This article is cited by
-
The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression
Cancer Cell International (2024)
-
Overexpression of Rsf-1 correlates with poor survival and promotes invasion in non-small cell lung cancer
Virchows Archiv (2017)
-
Rsf-1 overexpression in human prostate cancer, implication as a prognostic marker
Tumor Biology (2014)
-
Rsf-1 overexpression serves as a prognostic marker in human hepatocellular carcinoma
Tumor Biology (2014)
-
Rsf-1 overexpression correlates with poor prognosis and cell proliferation in colon cancer
Tumor Biology (2012)